MG Therapy Efgartigimod Boosts Platelet Counts in Patients With Chronic ITP
Efgartigimod, a treatment for generalized myasthenia gravis (MG), boosts platelet counts in patients with ITP, research shows.
Efgartigimod, a treatment for generalized myasthenia gravis (MG), boosts platelet counts in patients with ITP, research shows.